GenSight Biologics Announces September 2026 Business Updates
GenSight Biologics Provides Summer 2026 Business and Clinical Development Updates GenSight Biologics, a biopharmaceutical company specializing in the development and commercialization of innovative gene therapies for retinal neurodegenerative diseases and…
Aptar and Aceso Therapeutics Collaborate to Advance Inhaled Antisense Therapy for Cystic Fibrosis
Aptar Pharma and Aceso Therapeutics Collaborate to Advance Inhaled ASO Therapy for Cystic Fibrosis Aptar Pharma, a global provider of drug delivery, dosing, protection technologies and development services, has announced…
Agilent Expands Digital Pathology Portfolio with U.S. Launch of S540MD Slide Scanner System
Agilent Launches S540MD Slide Scanner in the U.S. Following FDA Clearance Agilent Technologies Inc. has announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging…
Teleflex Highlights Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026
Teleflex Highlights Advanced Vascular Technologies at CIRSE 2026, Featuring Dynetic™-35 Stent System Teleflex Incorporated, a global provider of medical technologies, is set to showcase a range of innovative solutions at…
ZANVASTRO™ (Zilganersen) Receives FDA Approval as First and Only Disease-Modifying Treatment for Alexander Disease in Pediatric and Adult Patients
Ionis Pharmaceuticals Receives FDA Approval for ZANVASTRO, First Disease-Modifying Treatment for Alexander Disease Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) has announced that the U.S. Food and Drug Administration (FDA) has approved…
Stoke Therapeutics and Biogen Present Long-Term Data Supporting Zorevunersen’s Disease-Modifying Potential in Dravet Syndrome
Stoke Therapeutics and Biogen Present Long-Term Zorevunersen Data Supporting Potential Disease-Modifying Treatment for Dravet Syndrome Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company focused on restoring protein expression through RNA…
eGenesis Provides Clinical Update on EGEN-2784 Expanded Access Study in Kidney Failure Patients
eGenesis Reports Sustained Kidney Function and Successful Human Transplantation Following Genetically Engineered Pig Kidney Transplants eGenesis, a biotechnology company focused on developing genetically engineered organs designed for transplantation into humans,…
BNB Plus Corp. Appoints Three New Directors Following Strategic Review
BNB Plus Appoints Three New Directors to Support Strategic Transformation and Digital Infrastructure Growth BNB Plus Corp., referred to as “BNB Plus” or the “Company,” has announced the appointment of…
SinglePass Device Demonstrates 100% Technical Success and No Clinically Significant Bleeding in Multicenter Study
SinglePass Biopsy Closure Device Demonstrates 100% Technical Success and No Clinically Significant Bleeding in Multicenter Study SinglePass, Inc., developer of the SinglePass biopsy closure device, has announced the publication of…
Invivoscribe Launches Commercial Shipments of PrepQuant™ Systems for High-Sensitivity MRD Sample Preparation
Invivoscribe Begins Commercial Shipments of PrepQuant™ System to Advance High-Sensitivity MRD Testing Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, has announced the start of…
Segal Trials Launches CISCRP’s 8th Annual Medical Heroes Appreci-A-Thon
Segal Trials Employees Join CISCRP Medical Heroes Appreci-A-Thon to Honor Clinical Research Participants and Professionals More than 90 employees from Segal Trials are participating in the 8th Annual Medical Heroes…
Lōkahi Therapeutics Expands ai² Futures Lab Network Through SDSU Collaboration
Lōkahi Therapeutics Expands ai² Futures Lab Through New Partnership With San Diego State University Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), has announced a new collaboration with San…